Ghaidaa S. Hameed

Dr. Ghaidaa S. Hameed


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2025 in Al Mustansiriyah Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
NNNaamaa A. Naama
Naamaa A. Naama
GHGhaidaa S. Hameed
Ghaidaa S. Hameed
DHDalya Basil Hanna
Dalya Basil Hanna
ZMZainab H. Mahdi
Zainab H. Mahdi
Cefdinir (CEF) is classified as a third-generation cephalosporin within class IV of the Biopharmaceutical Classification System (BCS). Cefdinir has low solubility and permeability, which may reduce oral bioavailability. The aim of this research was the preparation of cefdinir ternary solid dispersion in order to enhance its solubility. Then, after evaluating this ternary SD, investigate its stability under harsh conditions. In addition, formulation and evaluation of CEF ternary SD as capsule dosage form. The ternary SD is prepared by the solvent evaporation method using CEF, curcumin, and polyvinylpyrrolidone k30 in a weight ratio of 1:1:1. The ternary SD is subject to evaluation using Differential Scanning Calorimetry (DSC), Powder X-ray Diffractometry (PXRD), and Fourier Transform Infrared Spectroscopy (FTIR), saturated solubility, release, antibacterial activity, and a two months stability study under conditions of 40 ºC and 75% relative humidity. Then, six different capsule formulas were prepared using different excipients; each formula contained 300 mg of CEF. The capsule formulas were subjected to pre-formulation and capsule evaluation tests, which included weight variation, drug content, disintegration time, and In-vitro dissolution tests. The selected optimum capsule formula was subjected to further antibacterial activity test. Evaluation of ternary SD showed that, the system is totally amorphous with enhanced dissolution, saturated solubility, and antibacterial activity compared to pure CEF. Stability studies showed that, ternary SD remains amorphous after two months. Compared to commercial capsules (Sefarin® 300 mg) and other formulas, the F6 formula released 90% of CEF in 30 min. Antibacterial activity test results showed that the F6 formula was active against Staphylococcus aureus and Proteus vulgaris bacterial isolate. This research concludes that CEF solubility, antibacterial activity enhancement, and stability insurance could be obtained by preparing CEF ternary SD. All the ternary SD prepared capsule formulas showed enhancements in release compared to commercial capsules.

29 December 2023 in Iraqi Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
MKMena Raid Khalil
Mena Raid Khalil
GHGhaidaa S. Hameed
Ghaidaa S. Hameed
DHDalya Basil Hanna
Dalya Basil Hanna
In this study azithromycin was formulated for the first time as co-amorphous system suppository system to achieve the maximum bioavailability and to avoid the side effect that might be with oral route which is associated with this drug during treatment of Corona virus secondary bacterial infection. In this study the co-amorphous system was characterized by Differential Scanning Calorimetry (DSC), Powder X-ray Diffractometry (PXRD) and Fourier Transform Infrared Spectroscopy (FTIR). Eight different suppository formulas were prepared, these formulas were subjected to the dissolution test by Ph. Eur. Apparatus I (basket apparatus). The antibacterial activity was measured by the agar well-diffusion method. The results revealed the formation co-amorphous system. The formula in co-amorphous system with glycerin showed the best release for both azithromycin and curcumin. The combination and co-amorphous system showed double value of zone of inhibition rather than the drugs alone. This study will be interested in drugs company to find alternative rout of drug administration for serious infection that associated with GIT symptoms.

1 January 2019 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
JAJoseph Ali
Joseph Ali
Atheer ZgairAtheer Zgair
Atheer Zgair
GHGhaidaa S. Hameed
Ghaidaa S. Hameed
MGMartin C. Garnett
Martin C. Garnett
CRClive J Roberts
Clive J Roberts
PGPavel Gershkovich
Pavel Gershkovich
The oral cavity is of great importance to the performance of orally retained formulations, including: orally disintegrating tablets, taste-masked formulations, and buccal/sublingual delivery systems. With regards to in vitro dissolution assessment of these dosage forms, human saliva should be represented by the dissolution media. Currently there is no general consensus regarding oral cavity dissolution. In this study pooled human saliva was characterised and utilised as dissolution media for biorelevant oral cavity dissolution studies and to assess drug release. Lipophilic drug felodipine with challenging biopharmaceutical properties was selected for assessment in oral cavity dissolution studies. These saliva dissolution studies investigated for the first time how biorelevant dissolution can be implemented as a screening tool to guide the formulation development process and to predict dosage form performance within the mouth. In this study a combination of three dissolution enhancement strategies (cryomilling, solid dispersion, and inclusion complexation) were employed to eventually increase the concentration of felodipine in saliva 150-fold. Using this successful formulation strategy orally disintegrating tablets of felodipine were produced. Interestingly, the percentage release of felodipine in compendial dissolution apparatus was shown to be over 80% after 10 min. On the other hand, saliva-based dissolution showed that percentage release of felodipine was only 0.2% after 10 min using the same formulation. This discrepancy in drug release between dissolution media highlights the need for biorelevant dissolution apparatus for the oral cavity to reliably assess performance of relevant dosage forms in vitro.

23 December 2022 in Iraqi Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
MMMasar Basim Mohsin Mohamed
Masar Basim Mohsin Mohamed
ZKZainab Saad Kadoori
Zainab Saad Kadoori
GHGhaidaa S. Hameed
Ghaidaa S. Hameed
This work targeted studying organogel as a potential floating system. Organgel has an excellent viscoelastic properties, floating system posses a depot property. Different formulations of 12-hydroxyoctadecanoic acid (HOA) in sesame oil were gelled and selecting F1, F3 and F5 HOA organogels for various examinations: tabletop rheology, optical microscopy, and oscillatory rheology studies. Also, the floating properties studies were conducted at in vitro and in-vivo levels. Lastly, the in-vitro release study using cinnarizine (CN) was to investigate the organogel depot property. Based on the results, the selected concentrations of HOA in sesame oil organogels showed temperature transitions from gel to sol higher than body temperature. These organogels scaffolds inner structures were a star-like shape. The formulation F5 HOA/SO organogels were developing higher storage modulus values, which resulted from the amplitude sweep study. Indeed, all the selected organogels were frequency sweep independent. The organogel’s in vitro floating properties were found positively proven our work’s aim and were buoyant for 24 hours as F5 HOA organogels remained for 12 hours in the rat’s stomach. The depot property showed the slow release of CN from F5 HOA/SO organogel and not more than 65% w/w of CN released after 24 hours.

28 February 2023 in Al Mustansiriyah Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
MKMena Raid Khalil
Mena Raid Khalil
GHGhaidaa S. Hameed
Ghaidaa S. Hameed
DHDalya Basil Hanna
Dalya Basil Hanna
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the virus that caused the COVID-19 pandemic. Initial symptoms include fever, cough, and dyspnea. Symptoms include nausea, vomiting, and abdominal pain, GIT involvement is also possible. The COVID-19 outbreak has increased the need for alternative medicine administration routes, particularly in public places. Buccal, sublingual, and rectal administration are all considered transmucosal methods. They are self-administration options for non-invasive systemic distribution. In addition, they are great for use in palliative and end-of-life care because of their quick onset of action and decreased first-pass metabolism. A mucosal atomization device allows for the intranasal administration of a parenteral formulation through nasal spray. Rectal mucosal absorption is comparable to that of the oral route, making the rectal route an extremely versatile and useful method of drug administration for a wide variety of medications. Covid-19 illness is treated with a variety of drugs, including anti-malaria medication (hydroxychloroquine), glucocorticoids (dexamethasone), antibiotics (azithromycin), and antiviral medications (favipiravir). This article discusses the route of drug administration for COVID-19, as well as symptoms, treatments, and the various ways it can be spread

18 May 2026 in Pharmacia
Verified
Journal Article
Open access
AOAsmaa A. Oleiwi
Asmaa A. Oleiwi
GHGhaidaa S. Hameed
Ghaidaa S. Hameed
Electrospinning technology could be a promising approach for fabricating nanofibrous wound dressings that would facilitate the controlled delivery of biologically active agents. This study involved the preparation of quercetin-loaded poly(ε-caprolactone) (PCL)/chitosan (CH) electrospun nanofibers with different quercetin contents, namely 1–10 wt.% quercetin. Characterization of the obtained samples was performed with respect to morphology, physicochemical properties, encapsulation efficiency, in vitro drug release behavior, and in vivo wound healing activity. The morphology of the materials was evaluated by FE-SEM. XRD and FTIR were used to confirm the incorporation of quercetin into PCL/CH nanofibers. Quercetin addition at moderate concentrations did not adversely affect fiber formation, whereas high concentrations caused significant morphological alterations. XRD and FTIR data revealed effective drug incorporation and amorphous dispersion within the polymer matrix. The entrapment efficiency of quercetin decreased as the amount of drug increased. In vitro drug release studies in PBS demonstrated a sustained drug release pattern over the investigated period of 170 h; the release behavior was formulation-dependent. The obtained materials were shown to facilitate the enhancement of wound healing and collagen deposition when tested in vivo in comparison with blank PCL scaffolds.